Self-management Interventions for Advanced Breast Cancer

October 8, 2018 updated by: Duke University

Self-management Interventions for Pain in Advanced Breast Cancer

The purpose of this research study is to evaluate whether self-management discussion groups are helpful for women with advanced breast cancer who are experiencing pain. The study is looking at the usefulness of two different types of discussion groups, one of which also includes gentle exercise.

Study Overview

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27708
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • diagnosis of Stage IV breast cancer or recurrent metatastic breast cancer
  • receiving care at Duke Cancer Institute,
  • life expectancy ≥9 months as estimated by the treating oncologist,
  • speak and read English,
  • be at least age 18
  • be able to travel to the Duke Cancer Institute

Exclusion Criteria:

  • cognitive impairment as assessed by the 6-item Mini-mental Status Exam,
  • Karnofsky Performance Rating of <60 as rated by the oncology provider, an ECOG rating of 0-2
  • treatment for serious psychiatric illness (e.g., schizophrenia, severe depression) in the past 6 months,
  • currently engaged in yoga practice ≥ 1 day per week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: discussion group
Eight weekly group sessions in which participants will engage in discussions regarding issues related to coping with advanced cancer and pain
Participants engage in discussions regarding issues related to coping with advanced cancer and pain
Active Comparator: discussion group + exercise
Eight weekly group sessions in which participants will engage in discussions regarding issues related to coping with advanced cancer and pain and learn gentle exercise and breathing techniques
Participants engage in discussions regarding issues related to coping with advanced cancer and pain
Patients learn gentle exercise and breathing techniques

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility
Time Frame: 36 months
Feasibility will be indicated by our ability to meet accrual goals, and by at least 70% of patients attending ≥4 of 8 sessions and providing post-test assessments
36 months
Acceptability
Time Frame: 36 months
Acceptability will be assessed via participant ratings on a standardized measure of treatment effectiveness/satisfaction, supplemented by exit interview
36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain
Time Frame: study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
pain intensity as assessed by the Brief Pain Inventory
study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Change in fatigue
Time Frame: study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Fatigue as assessed by the Brief Fatigue Inventory
study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Change in sleep disturbance
Time Frame: study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Sleep disturbance as assessed by the Pittsburgh Sleep Quality Index
study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Change in Psychological distress
Time Frame: study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Anxiety and depression assessed using the Hospital Anxiety and Depression Scale
study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Change in functional capacity
Time Frame: study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months
Functional capacity assessed using a 6-minute walk test
study entry, following completion of the intervention (approximately 3 months), 6 months, and 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Laura Porter, PhD, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

November 20, 2017

Study Completion (Actual)

November 20, 2017

Study Registration Dates

First Submitted

August 16, 2013

First Submitted That Met QC Criteria

August 19, 2013

First Posted (Estimate)

August 22, 2013

Study Record Updates

Last Update Posted (Actual)

October 9, 2018

Last Update Submitted That Met QC Criteria

October 8, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00044446

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Breast Cancer Stage IV

Clinical Trials on discussion group

Subscribe